LU86769A1 - Nouvelles quinazolinones tetracycliques,leur preparation et leur utilisation comme medicaments - Google Patents

Nouvelles quinazolinones tetracycliques,leur preparation et leur utilisation comme medicaments Download PDF

Info

Publication number
LU86769A1
LU86769A1 LU86769A LU86769A LU86769A1 LU 86769 A1 LU86769 A1 LU 86769A1 LU 86769 A LU86769 A LU 86769A LU 86769 A LU86769 A LU 86769A LU 86769 A1 LU86769 A1 LU 86769A1
Authority
LU
Luxembourg
Prior art keywords
compound
compounds
pharmaceutically acceptable
formula
acid addition
Prior art date
Application number
LU86769A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU86769A1 publication Critical patent/LU86769A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
LU86769A 1986-02-13 1987-02-12 Nouvelles quinazolinones tetracycliques,leur preparation et leur utilisation comme medicaments LU86769A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/829,594 US4760065A (en) 1986-02-13 1986-02-13 Trifluoromethyl substituted tetracyclic quinazolin-ones having tranquilizing activity
US82959486 1986-02-13

Publications (1)

Publication Number Publication Date
LU86769A1 true LU86769A1 (fr) 1987-09-15

Family

ID=25254954

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86769A LU86769A1 (fr) 1986-02-13 1987-02-12 Nouvelles quinazolinones tetracycliques,leur preparation et leur utilisation comme medicaments

Country Status (22)

Country Link
US (1) US4760065A (nl)
JP (1) JPS62223183A (nl)
KR (1) KR870007900A (nl)
AT (1) AT390062B (nl)
AU (1) AU597936B2 (nl)
BE (1) BE1002099A3 (nl)
CH (1) CH671019A5 (nl)
DE (1) DE3702943A1 (nl)
DK (1) DK69787A (nl)
ES (1) ES2004215A6 (nl)
FI (1) FI870510A (nl)
FR (1) FR2601013A1 (nl)
GB (1) GB2186574B (nl)
GR (1) GR870232B (nl)
HU (1) HU198932B (nl)
IL (1) IL81536A0 (nl)
IT (1) IT1216790B (nl)
LU (1) LU86769A1 (nl)
NL (1) NL8700233A (nl)
NZ (1) NZ219242A (nl)
SE (1) SE8700566L (nl)
ZA (1) ZA871077B (nl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU665207B2 (en) * 1991-07-29 1995-12-21 Warner-Lambert Company Quinazoline derivatives as acetylcholinesterase inhibitors
US6133002A (en) 1997-09-25 2000-10-17 Dsm N.V. Process for preparing optically active 2-amino-ω-oxoalkanoic acid derivatives
EP2447239A1 (en) * 2010-10-29 2012-05-02 Saltigo GmbH Copper-catalysed process for the production of substituted or unsubstituted trifluormethylated aryl and heteroaryl compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3280117A (en) * 1964-04-20 1966-10-18 Sandoz Ag Tricyclic quinazolinones
US3631046A (en) * 1969-05-28 1971-12-28 Sandoz Ag Tetracyclic quinazolin-ones
US3598823A (en) * 1969-05-28 1971-08-10 Sandoz Ag Tricyclic quinazolinones
US3772230A (en) * 1969-05-28 1973-11-13 Sandoz Ag Polyhydro-imidazo(1,5-a)pyrimidine-3(2h)-thione and pyrido(1,2-c)pyrimidine-1-thione
US4000275A (en) * 1969-11-24 1976-12-28 Eli Lilly And Company Immunosuppressants
BE760013A (fr) * 1969-12-18 1971-06-08 Smith Kline French Lab Imidazo et pyrimido -(2,1-b)quinazolines, leurs procedes de preparationet compositions pharmaceutiques en contenant
US3868372A (en) * 1971-07-09 1975-02-25 Sandoz Ag Organomercapto-substituted polyhydro imidazo{8 1,5-a{9 pyridenes and pyride{8 1,2-c{9 pyrimidines
US3963720A (en) * 1972-10-27 1976-06-15 Sandoz, Inc. Tetracyclic imidazo [2,1-b] quinazolinone derivatives
PH19788A (en) * 1981-09-16 1986-07-02 Sandoz Ag 1-substituted tricyclic quinazolinones,pharmaceutical composition containing same and method of use thereof
PH17745A (en) * 1981-09-16 1984-11-27 Sandoz Ag Trifluoromethyl substituted tricyclic quinazolinones
US4452787A (en) * 1981-09-16 1984-06-05 Sandoz, Inc. 1-Substituted tricyclic quinazolinones having biological activity as tranquilizers
FR2512674B1 (fr) * 1981-09-16 1986-01-10 Sandoz Sa Nouveaux derives tricycliques de la quinazolinone, leur preparation et medicaments contenant ces derives

Also Published As

Publication number Publication date
BE1002099A3 (fr) 1990-07-03
US4760065A (en) 1988-07-26
IL81536A0 (en) 1987-09-16
FI870510A0 (fi) 1987-02-09
AU6869487A (en) 1987-08-20
CH671019A5 (nl) 1989-07-31
JPS62223183A (ja) 1987-10-01
AT390062B (de) 1990-03-12
AU597936B2 (en) 1990-06-14
IT8747634A0 (it) 1987-02-12
FI870510A (fi) 1987-08-14
GB2186574B (en) 1990-03-28
GR870232B (en) 1987-06-12
IT1216790B (it) 1990-03-14
SE8700566L (sv) 1987-08-14
DK69787A (da) 1987-08-14
SE8700566D0 (sv) 1987-02-12
HU198932B (en) 1989-12-28
NL8700233A (nl) 1987-09-01
FR2601013A1 (fr) 1988-01-08
HUT43607A (en) 1987-11-30
DK69787D0 (da) 1987-02-11
KR870007900A (ko) 1987-09-22
ATA29687A (de) 1989-08-15
ES2004215A6 (es) 1988-12-16
GB2186574A (en) 1987-08-19
DE3702943A1 (de) 1987-08-20
ZA871077B (en) 1988-09-28
NZ219242A (en) 1990-04-26
GB8702938D0 (en) 1987-03-18

Similar Documents

Publication Publication Date Title
EP0165919B1 (fr) (R)-alpha-éthyl-2-oxo-1-pyrrolidineacétamide
EP0512901A1 (fr) Composés polycycliques aminés et leurs énantiomères, procédé pour leur préparation et compositions pharmaceutiques en contenant
EP0591040A1 (fr) Amides basiques quaternaires comme tachykinines antagonistes
CH651550A5 (fr) Derives de l'indole, leur preparation et compositions pharmaceutiques les contenant.
EP0307303B1 (fr) [(Pyrimidinyl-2)-aminoalkyl]-1 pipéridines, leur préparation et leur application en thérapeutique
EP0340064B1 (fr) Benzodiazépines, leur procédé et intermédiaires de préparation et leurs applications en thérapeutique
EP0252823B1 (fr) Nouveaux dérivés du 1H, 3H-pyrrolo [1,2-c] thiazole, leur préparation et les compositions pharmaceutiques qui les contiennent
EP0253711B1 (fr) Nouveaux dérivés du 1H,3H-Pyrrolo [1,2-c] thiazole, leur préparation et les Compositions pharmaceutiques qui les contiennent
EP0732334A1 (fr) Dérivés de pipéridine, leur procédé de préparation et leur application en thérapeutique
WO1994007893A1 (fr) DERIVES DE 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT
CA2271072A1 (fr) Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-ylmethyle, leur preparation et leur application en therapeutique
EP0004494B1 (fr) Nouveaux dérivés de 1,3-dihydro 3-(1-(2-(2,3-dihydro 1,4-benzo-dioxin-2-yl)2-hydroxy éthyl)pipéridin-4-yl)2H-indol 2-one, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
EP0524055A1 (fr) Dérivés d'imidazo[2,1-b]benzothiazole-3-acétamide, leur préparation et leur application en thérapeutique
EP0607076A1 (fr) Dérivés de 9h-imidazo 1,2-a benzimidazole-3-acétamide à activité GABA
WO1995001334A1 (fr) Composes indoliques derives d'arylamines comme ligands selectifs des recepteurs 5ht1d et 5ht¿1b?
EP2094674A1 (en) A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
EP0385848A1 (fr) Nouveaux dérivés benzoxazolinoniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
LU86769A1 (fr) Nouvelles quinazolinones tetracycliques,leur preparation et leur utilisation comme medicaments
LU86405A1 (fr) Derive antipsychotique du benzisothiazole s-oxyde
EP0975631A1 (fr) Derives de 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one en tant que ligands des recepteurs 5-ht4
EP1119564B1 (fr) Derives d'aryl- 4-fluoro-4- (2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl -methanone comme agonistes du recepteur 5-ht1
FR2609715A1 (fr) Nouveaux diazepinoindoles, leur preparation et leur utilisation comme medicaments
LU87122A1 (fr) Nouveaux derives de la pilocarpine,leur preparation et leur utilisation comme medicaments
WO2000006552A1 (fr) Derives de 4-phenyl- et de 4,5-diphenylimidazoles, leur preparation et leur application en therapeutique
WO1999032485A1 (fr) Derives de 3-oxazol-5-yl-1-oxo-1,2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique